InsiderTrades.com logo

DERM Insider Trading

Insider Ownership Percentage: 15.03%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $589,228.83

Journey Medical Insider Trading History Chart

This chart shows the insider buying and selling history at Journey Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Journey Medical Share Price & Price History

Current Price: $7.81
Price Change: ▲ Price Increase of +0.12 (1.56%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for DERM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Journey Medical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/2/2025Claude MaraouiCEOSell4,834$6.84$33,064.562,348,313View SEC Filing Icon  
5/2/2025Ramsey AlloushCOOSell2,857$6.84$19,541.88504,817View SEC Filing Icon  
3/11/2025Claude MaraouiCEOSell49,271$5.01$246,847.712,003,147View SEC Filing Icon  
3/7/2025Claude MaraouiCEOSell14,905$5.01$74,674.052,052,418View SEC Filing Icon  
3/5/2025Claude MaraouiCEOSell18,147$5.13$93,094.112,092,874View SEC Filing Icon  
3/3/2025Claude MaraouiCEOSell23,508$5.19$122,006.522,139,922View SEC Filing Icon  
8/1/2024Joseph BeneschCFOSell9,324$5.47$51,002.2847,331View SEC Filing Icon  
7/23/2024Joseph BeneschCFOSell4,055$5.40$21,897.0056,655View SEC Filing Icon  
3/25/2024Lindsay A Md RosenwaldDirectorBuy10,000$3.04$30,400.00144,245View SEC Filing Icon  
3/22/2024Claude MaraouiCEOBuy10,000$3.48$34,800.002,163,430View SEC Filing Icon  
3/22/2024Justin Adam SmithDirectorBuy30,000$3.47$104,100.00134,717View SEC Filing Icon  
2/22/2024Joseph BeneschCFOSell2,450$3.75$9,187.5060,710View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Journey Medical (NASDAQ:DERM)

7.25% of Journey Medical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at DERM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Journey Medical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Wasatch Advisors LP1,306,272$9.30M0.0%+13.4%4.965%Search for SEC Filing on Google Icon
11/17/2025Integrated Wealth Concepts LLC44,350$0.32M0.0%-19.9%0.169%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC14,390$0.10M0.0%N/A0.055%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE21,537$0.15M0.0%+421.0%0.082%Search for SEC Filing on Google Icon
11/14/2025Creative Planning50,500$0.36M0.0%+54.1%0.192%Search for SEC Filing on Google Icon
11/14/2025Occudo Quantitative Strategies LP15,470$0.11M0.0%N/A0.059%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG145,220$1.03M0.0%-8.5%0.552%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.8,572$61K0.0%N/A0.033%Search for SEC Filing on Google Icon
11/12/2025Legato Capital Management LLC101,896$0.73M0.1%+49.8%0.387%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.615,229$4.38M0.0%+8.9%2.338%Search for SEC Filing on Google Icon
11/6/2025Essex Investment Management Co. LLC354,021$2.52M0.4%+55.1%1.346%Search for SEC Filing on Google Icon
11/5/2025Envestnet Asset Management Inc.60,950$0.43M0.0%-12.9%0.232%Search for SEC Filing on Google Icon
11/3/2025New York State Common Retirement Fund5,500$39K0.0%-61.5%0.021%Search for SEC Filing on Google Icon
10/22/2025Gladstone Institutional Advisory LLC28,571$0.20M0.0%-13.0%0.109%Search for SEC Filing on Google Icon
10/21/2025SJS Investment Consulting Inc.15,000$0.11M0.0%N/A0.057%Search for SEC Filing on Google Icon
10/8/2025Sheets Smith Investment Management132,904$0.95M0.6%N/A0.505%Search for SEC Filing on Google Icon
10/7/2025Salem Investment Counselors Inc.12,100$86K0.0%N/A0.046%Search for SEC Filing on Google Icon
9/2/2025PVG Asset Management Corp149,764$1.08M3.7%-14.1%0.614%Search for SEC Filing on Google Icon
8/15/2025Wasatch Advisors LP1,152,059$8.27M0.0%+23.8%4.944%Search for SEC Filing on Google Icon
8/15/2025Opaleye Management Inc.95,000$0.68M0.1%+37.0%0.408%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE4,134$30K0.0%+4,707.0%0.018%Search for SEC Filing on Google Icon
8/14/2025Raymond James Financial Inc.5,000$36K0.0%N/A0.021%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.6,623$48K0.0%N/A0.028%Search for SEC Filing on Google Icon
8/14/2025Pale Fire Capital SE32,458$0.23M0.0%+19.0%0.139%Search for SEC Filing on Google Icon
8/13/2025New York State Common Retirement Fund14,300$0.10M0.0%N/A0.061%Search for SEC Filing on Google Icon
8/13/2025Quadrature Capital Ltd13,181$94K0.0%N/A0.057%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.5,736$41K0.0%N/A0.025%Search for SEC Filing on Google Icon
8/8/2025Cetera Investment Advisers10,731$77K0.0%-29.2%0.046%Search for SEC Filing on Google Icon
8/8/2025Creative Planning32,764$0.24M0.0%+178.5%0.141%Search for SEC Filing on Google Icon
8/8/2025Police & Firemen s Retirement System of New Jersey4,002$29K0.0%N/A0.017%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC262,353$1.88M0.0%+130.7%1.126%Search for SEC Filing on Google Icon
8/4/2025Atria Investments Inc37,185$0.27M0.0%-16.7%0.160%Search for SEC Filing on Google Icon
8/1/2025Envestnet Asset Management Inc.69,991$0.50M0.0%-32.1%0.300%Search for SEC Filing on Google Icon
7/31/2025Brighton Jones LLC16,820$0.12M0.0%-26.9%0.072%Search for SEC Filing on Google Icon
7/31/2025Focus Partners Advisor Solutions LLC10,000$72K0.0%N/A0.043%Search for SEC Filing on Google Icon
5/21/2025Acadian Asset Management LLC4,772$28K0.0%-72.5%0.021%Search for SEC Filing on Google Icon
5/19/2025Jane Street Group LLC18,599$0.11M0.0%N/A0.081%Search for SEC Filing on Google Icon
5/16/2025Integrated Wealth Concepts LLC56,850$0.34M0.0%-3.4%0.246%Search for SEC Filing on Google Icon
5/15/2025Titleist Asset Management LLC12,900$76K0.0%+18.3%0.056%Search for SEC Filing on Google Icon
5/14/2025Pale Fire Capital SE27,274$0.16M0.0%N/A0.118%Search for SEC Filing on Google Icon
5/13/2025Kovitz Investment Group Partners LLC21,710$0.13M0.0%-12.1%0.094%Search for SEC Filing on Google Icon
4/22/2025Cambridge Investment Research Advisors Inc.338,050$1.99M0.0%+3.0%1.463%Search for SEC Filing on Google Icon
2/17/2025Tang Capital Management LLC1,725,569$6.75M0.4%N/A8.260%Search for SEC Filing on Google Icon
2/17/2025Cetera Investment Advisers13,839$54K0.0%+21.8%0.066%Search for SEC Filing on Google Icon
2/17/2025Citadel Advisors LLC44,568$0.17M0.0%N/A0.213%Search for SEC Filing on Google Icon
2/14/2025Kovitz Investment Group Partners LLC24,710$97K0.0%+112.9%0.118%Search for SEC Filing on Google Icon
2/14/2025Integrated Wealth Concepts LLC58,850$0.23M0.0%-4.1%0.282%Search for SEC Filing on Google Icon
2/14/2025Dimensional Fund Advisors LP20,455$80K0.0%N/A0.098%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC236,000$0.92M0.0%-12.0%1.130%Search for SEC Filing on Google Icon
2/13/2025Titleist Asset Management LLC10,900$43K0.0%-23.5%0.052%Search for SEC Filing on Google Icon
2/13/2025Envestnet Asset Management Inc.103,557$0.41M0.0%-5.5%0.496%Search for SEC Filing on Google Icon
1/29/2025Gladstone Institutional Advisory LLC29,981$0.12M0.0%-10.5%0.144%Search for SEC Filing on Google Icon
11/25/2024PVG Asset Management Corp167,545$0.95M3.8%+5.7%0.802%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC108,435$0.61M0.0%+13.5%0.523%Search for SEC Filing on Google Icon
11/15/2024Kovitz Investment Group Partners LLC11,605$66K0.0%N/A0.056%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC23,098$0.13M0.0%-63.7%0.111%Search for SEC Filing on Google Icon
11/12/2024Nwam LLC10,430$59K0.0%N/A0.050%Search for SEC Filing on Google Icon
11/1/2024Atria Investments Inc44,397$0.25M0.0%-19.8%0.214%Search for SEC Filing on Google Icon
10/30/2024Rosalind Advisors Inc.105,917$0.60M0.4%-7.2%0.529%Search for SEC Filing on Google Icon
10/11/2024ORG Wealth Partners LLC19,519$0.11M0.0%N/A0.094%Search for SEC Filing on Google Icon
8/22/2024PVG Asset Management Corp158,540$0.89M3.5%N/A0.792%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC264,025$1.49M0.0%-2.4%1.319%Search for SEC Filing on Google Icon
8/8/2024TMD Wealth Management LLC11,605$65K0.0%N/A0.058%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC94,404$0.53M0.0%-57.6%0.472%Search for SEC Filing on Google Icon
7/26/2024Cambridge Investment Research Advisors Inc.294,950$1.66M0.0%N/A1.474%Search for SEC Filing on Google Icon
7/12/2024Rosalind Advisors Inc.114,132$0.64M0.5%N/A0.570%Search for SEC Filing on Google Icon
5/14/2024Heron Bay Capital Management33,669$0.12M0.0%N/A0.169%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC222,663$0.82M0.0%+687.5%1.117%Search for SEC Filing on Google Icon
5/10/2024Perkins Capital Management Inc.22,000$81K0.1%-31.3%0.110%Search for SEC Filing on Google Icon
5/10/2024Nwam LLC11,820$41K0.0%N/A0.059%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Journey Medical logo
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm cream and solution an antifungal intended for topical use; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; and Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. In addition, the company sells sulconazole nitrate cream and solution indicated for the treatment of tinea cruris, tinea corporis, and tinea versicolor; and doxycycline hyclate tablets, as an adjunctive therapy for severe acne. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc.
Read More on Journey Medical

Today's Range

Now: $7.81
Low: $7.54
High: $8.01

50 Day Range

MA: $7.79
Low: $7.00
High: $9.19

52 Week Range

Now: $7.81
Low: $3.54
High: $9.40

Volume

76,828 shs

Average Volume

210,420 shs

Market Capitalization

$211.96 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.8

Who are the company insiders with the largest holdings of Journey Medical?

Journey Medical's top insider shareholders include:
  1. Claude Maraoui (CEO)
  2. Ramsey Alloush (COO)
  3. Lindsay A Md Rosenwald (Director)
  4. Justin Adam Smith (Director)
  5. Joseph Benesch (CFO)
Learn More about top insider investors at Journey Medical.

Who are the major institutional investors of Journey Medical?

Journey Medical's top institutional shareholders include:
  1. Wasatch Advisors LP — 4.96%
  2. Vanguard Group Inc. — 2.34%
  3. Essex Investment Management Co. LLC — 1.35%
  4. UBS Group AG — 0.55%
  5. Sheets Smith Investment Management — 0.51%
  6. Legato Capital Management LLC — 0.39%
Learn More about top institutional investors of Journey Medical stock.

Which major investors are selling Journey Medical stock?

Within the previous quarter, DERM stock was sold by these institutional investors:
  1. UBS Group AG
  2. Integrated Wealth Concepts LLC
  3. Envestnet Asset Management Inc.
  4. New York State Common Retirement Fund
  5. Gladstone Institutional Advisory LLC
Within the last year, company insiders that have sold Journey Medical company stock include:
  1. Claude Maraoui (CEO)
  2. Ramsey Alloush (COO)
Learn More investors selling Journey Medical stock.

Which major investors are buying Journey Medical stock?

Within the previous quarter, DERM stock was bought by institutional investors including:
  1. Wasatch Advisors LP
  2. Sheets Smith Investment Management
  3. Essex Investment Management Co. LLC
  4. Vanguard Group Inc.
  5. Legato Capital Management LLC
  6. Creative Planning
  7. Bank of America Corp DE
  8. Occudo Quantitative Strategies LP
Within the previous year, these company insiders have bought Journey Medical stock:
  1. Claude Maraoui (CEO)
  2. Ramsey Alloush (COO)
  3. Lindsay A Md Rosenwald (Director)
Learn More investors buying Journey Medical stock.